ACHV
Achieve Life SciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
ACHV vs peer average
39/100
ACHV vs. peer average (C vs. B)
Grade spread
A 3 · B 3 · C 1 · D 1 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
DRUG is the first available peer comparator.
Bright Minds Biosciences is mainly a small-cap development-stage biotech size/stage comp rather than a direct nicotine-dependence peer; useful for financing and binary-risk framing, but not for indication-specific commercialization comps.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACHV
Achieve Life Sciences
DRUG
Bright Minds Biosciences
Grade
C
D
Momentum
82
22
Value
41
41
Sentiment
36
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs DRUG
ACHV / DRUG
Grade Position
Below peers
ACHV vs. peer average (C vs. B)
39/100
Momentum
82
ACHVValue
41
ACHVSentiment
36
DRUGRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACHV
DRUG is the first peer returned for this comparison set.